Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Jill Shanor, NP
Nurse Practitioner · BUTLER, PA · NPI 1851860308
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Pantoprazole Sodium | Pantoprazole Sodium | 362 | 42 |
| Gabapentin | Gabapentin | 332 | 31 |
| Levothyroxine Sodium | Levothyroxine Sodium | 295 | 29 |
| Lisinopril | Lisinopril | 267 | 25 |
| Atorvastatin Calcium | Atorvastatin Calcium | 261 | 30 |
| Potassium Chloride | Potassium Chloride | 242 | 24 |
| Famotidine | Famotidine | 229 | 27 |
| Metoprolol Succinate | Metoprolol Succinate | 211 | 24 |
| Duloxetine Hcl | Duloxetine Hcl | 188 | 16 |
| Furosemide | Furosemide | 187 | 19 |
| Sertraline Hcl | Sertraline Hcl | 163 | 18 |
| Escitalopram Oxalate | Escitalopram Oxalate | 134 | 13 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 130 | 15 |
| Quetiapine Fumarate | Quetiapine Fumarate | 120 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 118 | 14 |
| Amlodipine Besylate | Amlodipine Besylate | 115 | 14 |
| Eliquis | Apixaban | 109 | 14 |
| Metformin Hcl | Metformin Hcl | 97 | 11 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 95 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 92 | 11 |
| Tamsulosin Hcl | Tamsulosin Hcl | 92 | suppressed |
| Omeprazole | Omeprazole | 77 | 12 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 73 | 11 |
| Simvastatin | Simvastatin | 68 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 66 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 66 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 66 | suppressed |
| Losartan Potassium | Losartan Potassium | 65 | suppressed |
| Aripiprazole | Aripiprazole | 63 | suppressed |
| Bumetanide | Bumetanide | 62 | suppressed |
| Levetiracetam | Levetiracetam | 62 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 56 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 55 | suppressed |
| Ezetimibe | Ezetimibe | 54 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 53 | suppressed |
| Xarelto | Rivaroxaban | 53 | suppressed |
| Prednisone | Prednisone | 51 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 50 | suppressed |
| Bupropion Xl | Bupropion Hcl | 49 | suppressed |
| Baclofen | Baclofen | 48 | suppressed |
| Clozapine | Clozapine | 47 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 46 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 46 | suppressed |
| Pregabalin | Pregabalin | 46 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 45 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 45 | suppressed |
| Ranolazine Er | Ranolazine | 44 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 43 | suppressed |
| Trulicity | Dulaglutide | 42 | suppressed |
| Carvedilol | Carvedilol | 41 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 40 | suppressed |
| Latanoprost | Latanoprost | 40 | suppressed |
| Mirtazapine | Mirtazapine | 40 | suppressed |
| Allopurinol | Allopurinol | 39 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 39 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 38 | 12 |
| Mounjaro | Tirzepatide | 38 | suppressed |
| Spironolactone | Spironolactone | 38 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 38 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 37 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 37 | suppressed |
| Celecoxib | Celecoxib | 36 | suppressed |
| Ramipril | Ramipril | 35 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 34 | suppressed |
| Lorazepam | Lorazepam | 32 | suppressed |
| Topiramate | Topiramate | 32 | suppressed |
| Valsartan | Valsartan | 31 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 30 | 30 |
| Digoxin | Digoxin | 30 | suppressed |
| Buprenorphine | Buprenorphine | 27 | suppressed |
| Memantine Hcl | Memantine Hcl | 27 | suppressed |
| Methylprednisolone | Methylprednisolone | 27 | 23 |
| Phenobarbital | Phenobarbital | 27 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 26 | suppressed |
| Dutasteride-Tamsulosin | Dutasteride/Tamsulosin Hcl | 26 | suppressed |
| Irbesartan | Irbesartan | 26 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 26 | suppressed |
| Phenytek | Phenytoin Sodium Extended | 26 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 25 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 25 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 25 | suppressed |
| Lamotrigine | Lamotrigine | 25 | suppressed |
| Clonazepam | Clonazepam | 24 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 24 | suppressed |
| Glipizide Er | Glipizide | 24 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 24 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 24 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 22 | suppressed |
| Atenolol | Atenolol | 21 | suppressed |
| Ibuprofen | Ibuprofen | 21 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 21 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 21 | suppressed |
| Temazepam | Temazepam | 21 | suppressed |
| Lumigan | Bimatoprost | 20 | suppressed |
| Carbamazepine | Carbamazepine | 19 | suppressed |
| Mirabegron Er | Mirabegron | 19 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 19 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 19 | 13 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 18 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 18 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 18 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 17 | suppressed |
| Xifaxan | Rifaximin | 17 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 16 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 16 | suppressed |
| Veltassa | Patiromer Calcium Sorbitex | 16 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 15 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 15 | suppressed |
| Loperamide | Loperamide Hcl | 15 | suppressed |
| Olanzapine | Olanzapine | 15 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 15 | suppressed |
| Topiramate Er | Topiramate | 15 | suppressed |
| Fentanyl | Fentanyl | 14 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 14 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 13 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 13 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 13 | suppressed |
| Cevimeline Hcl | Cevimeline Hcl | 13 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 13 | suppressed |
| Elmiron | Pentosan Polysulfate Sodium | 13 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 13 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 13 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 13 | suppressed |
| Haloperidol | Haloperidol | 13 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 13 | suppressed |
| Januvia | Sitagliptin Phosphate | 13 | suppressed |
| Lithium Carbonate Er | Lithium Carbonate | 13 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 13 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 13 | suppressed |
| Meloxicam | Meloxicam | 13 | suppressed |
| Novofine 32 | Pen Needle, Diabetic | 13 | suppressed |
| Olanzapine-Fluoxetine Hcl | Olanzapine/Fluoxetine Hcl | 13 | suppressed |
| Primidone | Primidone | 13 | suppressed |
| Repatha Sureclick | Evolocumab | 13 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 13 | suppressed |
| Sucralfate | Sucralfate | 13 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 13 | suppressed |
| Trimethoprim | Trimethoprim | 13 | suppressed |
| Trospium Chloride | Trospium Chloride | 13 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 12 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 12 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 12 | suppressed |
| Lacosamide | Lacosamide | 12 | suppressed |
| Myrbetriq | Mirabegron | 12 | suppressed |
| Rezvoglar Kwikpen | Insulin Glargine-Aglr | 12 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 11 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 11 | suppressed |
| Gemfibrozil | Gemfibrozil | 11 | suppressed |
| Leucovorin Calcium | Leucovorin Calcium | 11 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 11 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 11 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 11 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 11 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error